Previous close | 21.47 |
Open | 21.29 |
Bid | 19.80 x 200 |
Ask | 19.89 x 100 |
Day's range | 19.78 - 21.78 |
52-week range | 13.36 - 27.50 |
Volume | |
Avg. volume | 324,269 |
Market cap | 530.712M |
Beta (5Y monthly) | -0.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | -6.08 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 45.22 |
AnaptysBio (ANAB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders will have a reason to smile today, with the analysts making substantial...
AnaptysBio, Inc. (ANAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).